FacebookTwitterRedditEmail

The Mother of All Side Effects

Americans are getting used to the withdrawal or severe restriction of drugs “previously thought safe.” From last year’s Avandia warnings to the withdrawal of Vioxx, Bextra, Baycol, Meridia, Trovan and Fen Phen, “Pill Buyer Beware” seems to be a shrewd stance, especially when a drug is new.

Still, the parade of heart, liver and muscle complications seen with withdrawn drugs has lacked the side effect that sends shivers down the spines of consumers, regulators and drug-makers: birth defects.

But this month FDA issued a warning that pregnant women who take the antiepileptic drug Topamax are twenty times as likely to have their babies develop cleft lip and cleft palate as they would otherwise be, says Reuters. Children are three times as likely to develop the facial anomalies as infants exposed to other seizure drugs, adds the Associated Press.

Johnson & Johnson’s Topamax is FDA-approved to treat seizures and migraine headache. But like the off-label marketed seizure drugs Neurontin and Lyrica (for which Pfizer paid massive fines), J & J agreed to a $6.1 million fine for illegally marketing Topamax for psychiatric conditions, less than a year ago.

And the marketing worked. Thanks to J & J’s subsidiary Ortho-McNeil’s “Doctor-for-a-Day” scheme in which it paid outside physicians to call on health care providers along with sales reps and speak at meetings and dinners, according to the AP, Topamax made J & J a cool $2 billion a year by 2006. (A lot less than the $6.1 million it paid in criminal fines for the marketing that made the $2 billion.)

Thanks to wide marketing, Topamax has become such a catch-all drug in the military for general pain conditions and other unapproved uses (often in untested psychoactive drug “cocktails” which are now under investigation) it’s called “Stupamax” because of its brain-fogging properties says Army Times.

Nor is this month’s alert the first safety warning for Topamax.

As early as 2004, FDA warned J & J its sales pieces downplayed the “serious side effects associated with Topamax, including oligohidrosis (decreased sweating), hyperthermia, and metabolic acidosis,” a violation of the Federal Food, Drug and Cosmetic Act. “These materials raise serious public health concerns because they encourage the unsafe use of Topamax, including, particularly, in pediatric patients,” said FDA.

In 2006, FDA warned that Topamax can cause a serious eye condition “characterized by acute myopia and secondary angle closure glaucoma.” The eye side effects can lead to “permanent loss of vision,” if medical care is not sought, says the prescribing information.

In 2008, FDA warned that patients on all antiepileptic drugs should be “monitored for the emergence or worsening of depression, suicidal thoughts or behavior, or any unusual changes in mood or behavior,” and warnings on drug labels were soon required.

And last year FDA refused to approved a diet drug candidate, Qnexa, which includes Topamax along with phentermine, the “good” drug in the Fen Phen combo, because of surfacing Topamax doubts.

Qnexa probably would have worked as a diet drug. People who have used Topamax on the drug rating site askapatient say it does decrease appetite. But the action stems from Topamax making food and drinks taste terrible write more than 33 people. Others say in addition to making you lose weight, Topamax makes you lose your memory, word recall and even hair. Line forms to the left.

Of course widely promoted drugs which turn out to be dangerous after millions use them is nothing new. Many are calling for an end to the pharma Wild West in which even after fines for illegal drug marketing and personal injury settlements, pharma still profits and no principals go to jail.

Especially after Topamax’s new side effects.

MARTHA ROSENBERG can be reached at: martharosenberg@sbcglobal.net

 

More articles by:

Martha Rosenberg is an investigative health reporter. She is the author of  Born With A Junk Food Deficiency: How Flaks, Quacks and Hacks Pimp The Public Health (Prometheus).

bernie-the-sandernistas-cover-344x550
July 24, 2019
Elliot Sperber
The Parable of the Flax Seed 
July 23, 2019
Patrick Cockburn
Why Boris Johnson is Even More Dangerous Than Trump
Christopher Ketcham
The American West as Judeo-Christian Artifact
Jack Heyman
Whitewashing American History: the WPA Mural Controversy in San Francisco
David Mattson
Through the Climate Looking Glass into Grizzly Wonderland
David Macaray
Paul Krassner and Me
Thomas Knapp
Peckerwood Populism is About Political Strategy, Not Personal Belief
John Kendall Hawkins
Assange and His Wiki Wicked leaks
Howard Lisnoff
What Has Happened to the U.S. Since the Kids Left Woodstock?
Victor Grossman
“How Could They?” Why Some Americans Were Drawn to the Communist Party in the 1940s
Gary Leupp
Minnesota, White People, Lutherans and Ilhan Omar
Binoy Kampmark
Lunar Narratives: Landing on the Moon, Politics and the Cold War
Richard Ward
Free La Donalda!
July 22, 2019
Michael Hudson
U.S. Economic Warfare and Likely Foreign Defenses
Evaggelos Vallianatos
If Japan Continues Slaughtering Whales, Boycott the 2020 Tokyo Olympics
Mike Garrity
Emergency Alert For the Wild Rockies
Dean Baker
The U.S.-China Trade War: Will Workers Lose?
Jonah Raskin
Paul Krassner, 1932-2019: American Satirist 
David Swanson
U.S. Troops Back in Saudi Arabia: What Could Go Wrong?
Robert Fisk
American Visitors to the Gestapo Museum Draw Their Own Conclusions
John Feffer
Trump’s Send-Them-Back Doctrine
Kenn Orphan – Phil Rockstroh
Landscape of Anguish and Palliatives: Predation, Addiction and LOL Emoticons in the Age of Late Stage Capitalism
Karl Grossman
A Farmworkers Bill of Rights
Gary Leupp
Omar and Trump
Robert Koehler
Fighting Climate Change Means Ending War
Susie Day
Mexicans Invade US, Trump Forced to Go Without Toothbrush
Elliot Sperber
Hey Diddle Diddle, Like Nero We Fiddle
Weekend Edition
July 19, 2019
Friday - Sunday
Rob Urie
The Blob Fought the Squad, and the Squad Won
Miguel A. Cruz-Díaz
It Was Never Just About the Chat: Ruminations on a Puerto Rican Revolution.
Anthony DiMaggio
System Capture 2020: The Role of the Upper-Class in Shaping Democratic Primary Politics
Andrew Levine
South Carolina Speaks for Whom?
Jeffrey St. Clair
Roaming Charges: Big Man, Pig Man
Bruce E. Levine
The Groundbreaking Public Health Study That Should Change U.S. Society—But Won’t
Evaggelos Vallianatos
How the Trump Administration is Eviscerating the Federal Government
Pete Dolack
All Seemed Possible When the Sandinistas Took Power 40 years Ago
Ramzy Baroud
Who Killed Oscar and Valeria: The Inconvenient History of the Refugee Crisis
Ron Jacobs
Dancing with Dr. Benway
Joseph Natoli
Gaming the Climate
Marshall Auerback
The Numbers are In, and Trump’s Tax Cuts are a Bust
Louisa Willcox
Wild Thoughts About the Wild Gallatin
Kenn Orphan
Stranger Things, Stranger Times
Mike Garrity
Environmentalists and Wilderness are Not the Timber Industry’s Big Problem
Helen Yaffe
Cuban Workers Celebrate Salary Rise From New Economic Measures
Brian Cloughley
What You Don’t Want to be in Trump’s America
David Underhill
The Inequality of Equal Pay
FacebookTwitterRedditEmail